Education
About Us
Working with TipRanks
Follow Us
Samit Hirawat Insider Profile
18 Followers
Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev at Bristol-Myers Squibb, holds 83.51K shares in Bristol-Myers Squibb (Ticker: BMY), holds ― shares in Pacira Pharmaceuticals (Ticker: PCRX). Most recently, Samit Hirawat Bought ― shares of Bristol-Myers Squibb on Apr 29, 2025 for an estimated value of $202.22K.
Samit Hirawat Bristol-Myers Squibb (BMY)EVP,Chief Med.Offr.,Drug Dev
Bristol-Myers Squibb (BMY)
EVP,Chief Med.Offr.,Drug Dev
Ranked #36,621 out of 106,131 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+11.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Samit Hirawat holds in companies
Most Profitable Insider Trade
The most profitable trade made by Samit Hirawat
Samit Hirawat's Trading History
Bristol-Myers Squibb
Apr 29, 2025
EVP,Chief Med.Offr.,Drug Dev
Informative Buy
202.22K
$5.03M
Pacira Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Samit Hirawat's performance on stock
You May Also Like
Samit Hirawat insider profile FAQ
What is the percentage of profitable transactions made by Samit Hirawat?
The percentage of profitable transactions made by Samit Hirawat is 67%.
What is the average return per transaction made by Samit Hirawat?
The average return per transaction made by Samit Hirawat is 11.30%.
What stocks does Samit Hirawat hold?
Samit Hirawat holds: BMY, PCRX stocks.
What was Samit Hirawat’s latest transaction?
Samit Hirawat latest transaction was an Informative Buy of $202.22K.
What was Samit Hirawat's most profitable transaction?
Samit Hirawat’s most profitable transaction was an Informative Buy of BMY stock on April 29, 2025. The return on the trade was 31.60%.
What is Samit Hirawat's role in Bristol-Myers Squibb?
Samit Hirawat's role in Bristol-Myers Squibb is EVP,Chief Med.Offr.,Drug Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.